Can the stock continue its market-beating ways?…
TARRYTOWN, N.Y., Dec. 18, 2023 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) will webcast its presentation at…
Shares of Regeneron Pharmaceuticals Inc. sank 0.01% to $876.00 Thursday, on what proved to be an all-around favorable trading session…
…
The STRIDE study did not meet its primary or secondary efficacy endpoint…
New York (www.aktiencheck.de) - Rating-Update:
Die Analysten von Morgan Stanley stufen die Aktie von Regeneron Pharmaceuticals Inc. (ISIN: US75886F1075, WKN: 881535,…
The genetics sector supports every other life science industry in a variety of ways.One of its major contributions is the…
The genetics sector supports every other life science industry in a variety of ways.One of its major contributions is the…
New York (www.aktiencheck.de) - Rating-Update:
Die Analysten von TD Cowen stufen die Aktie von Regeneron Pharmaceuticals Inc. (ISIN: US75886F1075, WKN: 881535,…
Replimune Group Inc. shares REPL dropped more than 40% premarket on Tuesday after the biotech company said an investigational cancer…
…
New York (www.aktiencheck.de) - Regeneron Pharmaceuticals-Aktienanalyse von Jefferies & Co:
Akash Tewari, Analyst von Jefferies & Co, stuft die Aktie von…
Companies covered in this study are Novartis, AstraZeneca, Merck & Co., Inc, Bristol-Myers Squibb, Pfizer, Eli Lilly and Company, Gilead…
…
…
…
Milwaukee (www.aktiencheck.de) - Rating-Update:
Die Analysten von Robert W. Baird stufen die Aktie von Regeneron Pharmaceuticals Inc. (ISIN: US75886F1075, WKN: 881535,…
London (www.aktiencheck.de) - Rating-Update:
Barclays stuft die Aktie von Regeneron Pharmaceuticals Inc. (ISIN: US75886F1075, WKN: 881535, Ticker-Symbol: RGO, NASDAQ-Symbol: REGN) weiterhin…
Vancouver (www.aktiencheck.de) - Regeneron Pharmaceuticals-Aktienanalyse von Canaccord Genuity:
Die Analysten von Canaccord Genuity stufen die Aktie von Regeneron Pharmaceuticals Inc. (ISIN:…
St. Petersburg (www.aktiencheck.de) - Regeneron Pharmaceuticals-Aktienanalyse von Raymond James:
Dane Leone, Analyst von Raymond James, stuft in einer aktuellen Aktienanalyse die…
…
…
TARRYTOWN, N.Y., Nov. 02, 2023 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced financial results for…
…
Genetics is the study of genes, their variations and hereditary characteristics, as well as how these traits are passed on…
TARRYTOWN, N.Y., Oct. 25, 2023 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) will webcast management participation as…
Die Aktie von Regeneron Pharmaceuticals notiert heute ein wenig leichter. Zuletzt zahlten Investoren für das Wertpapier 799,11 US-Dollar. Heute hat…
TARRYTOWN, N.Y. and PARIS, Oct. 20, 2023 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Sanofi today…
Vancouver (www.aktiencheck.de) - Rating-Update:
Die Analysten von Canaccord Genuity bewerten die Aktie von Regeneron Pharmaceuticals Inc. (ISIN: US75886F1075, WKN: 881535, Ticker-Symbol:…
IRVINE, Calif., Oct. 06, 2023 (GLOBE NEWSWIRE) -- Reneo Pharmaceuticals, Inc. (Nasdaq: RPHM), a clinical stage pharmaceutical company…
TARRYTOWN, N.Y. and CAMBRIDGE, Mass., Oct. 03, 2023 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) and Intellia Therapeutics,…
Charlotte (www.aktiencheck.de) - Regeneron Pharmaceuticals-Aktienanalyse von BofA Securities:
Die Analysten von BofA Securities stufen in einer aktuellen Aktienanalyse die Aktie von…
TARRYTOWN, N.Y., Sept. 28, 2023 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that it will…
TARRYTOWN, N.Y., Sept. 25, 2023 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that it has…
[219 + Pages Report] According to a market research study published by Zion Market Research, the demand analysis of Global…
New York (www.aktiencheck.de) - Rating-Update:
Jasper Hellweg, Analyst von Argus Research, stuft die Aktie von Regeneron Pharmaceuticals Inc. (ISIN: US75886F1075, WKN:…
Regeneron Pharmaceuticals Inc. REGN said late Friday that Chief Financial Officer Robert E. Landry will retire in February, and…
Landry, Robert E. - Vorstand - Tag der Transaktion: 2023-08-23...…
Van Plew Daniel P. - Vorstand - Tag der Transaktion: 2023-08-24...…
Poon, Christine A. - Aufsichtsrat - Tag der Transaktion: 2023-08-23...…
Regeneron Pharmaceuticals, Gilead Sciences, Novavax, Apellis Pharmaceuticals and Fulcrum Therapeutics are part of the Zacks top Analyst Blog....…
The companys growth fuel isnt running out yet....…
TARRYTOWN, N.Y., Aug. 23, 2023 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) will webcast management participation as…
San Francisco (www.aktiencheck.de) - Rating-Update:
Mohit Bansal, Analyst von Wells Fargo Advisors, bewertet die Aktie von Regeneron Pharmaceuticals Inc. (ISIN:…
Regeneron Pharmaceuticals Inc (NASDAQ: REGN) was awarded a government contract valued at up to $326 million on Tuesday.
read more...…
London (www.aktiencheck.de) - Rating-Update:
Die Analysten von Barclays stufen die Aktie von Regeneron Pharmaceuticals Inc. (ISIN: US75886F1075, WKN: 881535, Ticker-Symbol: RGO,…
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Um den gesamten Artikel unter news.google.com zu lesen, klicken Sie bitte auf die Überschrift...…
Regeneron Pharmaceuticals Inc. REGN said Tuesday that the Biomedical Advanced Research and Development Authority has agreed to support the development,…